Clarivate (CLVT): Assessing Valuation After AI Launches and Strategic Subscription Shift

Simply Wall St

Clarivate (NYSE:CLVT) just rolled out fresh AI-powered tools for its Innography platform and outlined a big shift at a major industry conference. Its focus is moving to subscriptions, streamlining operations, and cutting debt.

See our latest analysis for Clarivate.

Clarivate’s recent AI launches and push for more predictable subscription revenue have certainly caught some attention, but that optimism has yet to translate into the share price. Over the past year, the company’s total shareholder return was -41.6%, suggesting that while management is making bold moves to improve fundamentals, the market remains cautious about whether these changes can reverse fading momentum.

If you’re curious where growth and innovation are showing up across the broader market, now is the perfect moment to broaden your search and discover fast growing stocks with high insider ownership

With Clarivate’s shares trading well below analyst targets and insiders recently buying in, the big question is whether the market is missing an opportunity here or if all the company’s future growth is already reflected in the current share price.

Most Popular Narrative: 24.4% Undervalued

According to the most widely followed perspective, Clarivate’s fair value is set at $5.14, significantly above the last close of $3.89. With Wall Street sharply divided about the company’s outlook, it is vital to examine what is driving this bullish valuation now.

Rapid expansion and adoption of AI-driven product innovation across all segments (including new AI-powered analytics in Web of Science, Derwent, and Cortellis) enhances product differentiation and workflow integration, driving higher pricing, customer retention, and potentially expanding gross margins.

Read the complete narrative.

Want a peek behind this big price target? The full narrative hints at some eye-popping forecasts for future profit margins and declining shares. Find out which bold growth assumptions and valuation metrics set the stage for Clarivate’s current attractiveness. Read on to learn what is fueling this optimism.

Result: Fair Value of $5.14 (UNDERVALUED)

Have a read of the narrative in full and understand what's behind the forecasts.

However, shifts in higher education funding and the rise of free research data could quickly challenge Clarivate’s subscription growth and pricing power.

Find out about the key risks to this Clarivate narrative.

Build Your Own Clarivate Narrative

If you think the story could unfold differently or want to see what your own research reveals, you can shape your own view in just minutes. Do it your way

A good starting point is our analysis highlighting 3 key rewards investors are optimistic about regarding Clarivate.

Looking for more investment ideas?

You owe it to yourself to see what else is out there. The right screen could reveal opportunities where smart investors are already positioning themselves for tomorrow’s gains.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Valuation is complex, but we're here to simplify it.

Discover if Clarivate might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.

Access Free Analysis

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com